FARSA

phenylalanyl-tRNA synthetase subunit alpha, the group of Aminoacyl tRNA synthetases, Class II

Basic information

Region (hg38): 19:12922479-12934037

Previous symbols: [ "FARSL", "FARSLA" ]

Links

ENSG00000179115NCBI:2193OMIM:602918HGNC:3592Uniprot:Q9Y285AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Rajab interstitial lung disease with brain calcifications 2 (Limited), mode of inheritance: AR
  • Rajab interstitial lung disease with brain calcifications 2 (Strong), mode of inheritance: AR
  • Rajab interstitial lung disease with brain calcifications 2 (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Rajab interstitial lung disease with brain calcifications 2AREndocrine; PulmonaryAn individual has been described with endocrine manifestations, including panhypopituitarism and hypothyroidism, and awareness may allow early diagnosis and medical management (eg, with hormone replacement therapy); The condition can include severe lung disease, and awareness may allow prompt diagnosis and management;Craniofacial; Endocrine; Gastrointestinal; Musculoskeletal; Neurologic; Pulmonary31355908

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FARSA gene.

  • not_specified (63 variants)
  • not_provided (12 variants)
  • FARSA-related_disorder (10 variants)
  • Rajab_interstitial_lung_disease_with_brain_calcifications_2 (8 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FARSA gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004461.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
8
clinvar
1
clinvar
10
missense
3
clinvar
1
clinvar
67
clinvar
1
clinvar
2
clinvar
74
nonsense
1
clinvar
1
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 3 1 69 9 3

Highest pathogenic variant AF is 0.00012824855

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FARSAprotein_codingprotein_codingENST00000314606 1311559
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01410.9861257190291257480.000115
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.222683300.8110.00002223283
Missense in Polyphen85131.060.648551351
Synonymous-0.06181381371.010.000009271001
Loss of Function3.54929.90.3010.00000175289

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004780.000478
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004760.0000462
European (Non-Finnish)0.0001160.000114
Middle Eastern0.000.00
South Asian0.00006530.0000653
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Pathway
Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Phenylalanine and Tyrosine Metabolism;Phenylketonuria;Tyrosinemia Type 3 (TYRO3);Tyrosinemia Type 2 (or Richner-Hanhart syndrome);tRNA Aminoacylation;Translation;Metabolism of proteins;tRNA charging;Cytosolic tRNA aminoacylation (Consensus)

Recessive Scores

pRec
0.200

Intolerance Scores

loftool
0.672
rvis_EVS
0.07
rvis_percentile_EVS
58.96

Haploinsufficiency Scores

pHI
0.307
hipred
Y
hipred_score
0.639
ghis
0.614

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
E
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.995

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Farsa
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); skeleton phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
phenylalanyl-tRNA aminoacylation;protein heterotetramerization
Cellular component
cytoplasm;cytosol;phenylalanine-tRNA ligase complex;membrane
Molecular function
tRNA binding;RNA binding;phenylalanine-tRNA ligase activity;protein binding;ATP binding